NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) (the "Company") today announced that it has priced an underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $5.50 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $46.2 million. The offering was increased to 9,000,000 shares of common stock from the previously announced base offering of 7,500,000 shares of common stock. The Company has granted the underwriters a 30-day option to purchase up to an additional 1,350,000 shares of common stock to cover overallotments, if any. The offering is expected to close on or about April 21, 2010, subject to satisfaction of customary closing conditions. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.
Study focuses on COPD progression in younger populations